The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Detection of Bladder Cancer Using a Point-of-Care Proteomic Assay
Abstract
CONTEXT: A combination of methods is used for diagnosis of bladder cancer because no single procedure detects all malignancies. Urine tests are frequently part of an evaluation, but have either been nonspecific for cancer or required specialized analysis at a laboratory. OBJECTIVE: To investigate whether a point-of-care proteomic test that measures the nuclear matrix protein NMP22 in voided urine could enhance detection of malignancy in patients with risk factors or symptoms of bladder cancer. DESIGN, SETTING, AND PATIENTS: Twenty-three academic, private practice, and veterans' facilities in 10 states prospectively enrolled consecutive patients from September 2001 to May 2002. Participants included 1331 patients at elevated risk for bladder cancer due to factors such as history of smoking or symptoms including hematuria and dysuria. Patients at risk for malignancy of the urinary tract provided a voided urine sample for analysis of NMP22 protein and cytology prior to cystoscopy. MAIN OUTCOME MEASURES: The diagnosis of bladder cancer, based on cystoscopy with biopsy, was accepted as the reference standard. The performance of the NMP22 test was compared with voided urine cytology as an aid to cancer detection. Testing for the NMP22 tumor marker was conducted in a blinded manner. RESULTS: Bladder cancer was diagnosed in 79 patients. The NMP22 assay was positive in 44 of 79 patients with cancer (sensitivity, 55.7%; 95% confidence interval [CI], 44.1%-66.7%), whereas cytology test results were positive in 12 of 76 patients (sensitivity, 15.8%; 95% CI, 7.6%-24.0%). The specificity of the NMP22 assay was 85.7% (95% CI, 83.8%-87.6%) compared with 99.2% (95% CI, 98.7%-99.7%) for cytology. The proteomic marker detected 4 cancers that were not visualized during initial endoscopy, including 3 that were muscle invasive and 1 carcinoma in situ. CONCLUSION: The noninvasive point-of-care assay for elevated urinary NMP22 protein can increase the accuracy of cystoscopy, with test results available during the patient visit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. J., Petros, J. A., & Andriole, G. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241702 · Cited by 2,361
Identification of a nuclear protein matrix
Berezney, R., & Coffey, D. S. (1974) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(74)90355-6 · Cited by 996
Superficial Bladder Cancer: Progression and Recurrence
Heney, N. M., Ahmed, S., Flanagan, M. J., Frable, W., Corder, M. P., Hafermann, M. D., Hawkins, I. R., & For National Bladder Cancer Collaborative Group A S002253471751695X-1bb6d6502e02ba4ea1210f9f5bd6022d George R. Prout The principal investigators and institutions that contributed to the study are, M. G. H. (1983) · Journal of Urology · doi:10.1016/s0022-5347(17)51695-x · Cited by 924
A fixed site of DNA replication in eucaryotic cells
Pardoll, D. M., Vogelstein, B., & Coffey, D. S. (1980) · Cell · doi:10.1016/0092-8674(80)90527-9 · Cited by 655
Screening for Prostatic Carcinoma with Prostate Specific Antigen
Brawer, M. K., CHETNER, M. P., Beatie, J., Büchner, D. M., Vessella, R. L., & Lange, P. H. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)37401-3 · Cited by 612
Mapping replicational sites in the eucaryotic cell nucleus.
Nakayasu, H., & Berezney, R. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.1.1 · Cited by 520
Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin Fluorescence
Kriegmair, M., Baumgartner, R., Knuchel, R., Stepp, H., Hofstadter, F., & Hofstetter, A. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)66559-5 · Cited by 434
Soloway, M. S., Briggman, J. V., Carpinito, G. A., Chodak, G. W., CHURCH, P. A., Lamm, D. L., Lange, P. H., Messing, E. M., Pasciak, R. M., Reservitz, G. B., et al. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)65851-8 · Cited by 331
Lydersen, B. K., & Pettijohn, D. E. (1980) · Cell · doi:10.1016/0092-8674(80)90359-1 · Cited by 241
Zaak, D., Kriegmair, M., Stepp, H., Stepp, H., Baumgartner, R., Oberneder, R., Schneede, P., Corvin, S., Frimberger, D., Knüchel, R., et al. (2001) · Urology · doi:10.1016/s0090-4295(00)01053-0 · Cited by 204
Cited by
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
Babjuk, M., Burger, M., Zigeuner, R., Shariat, S. F., van Rhijn, B. W. G., Compérat, E., Sylvester, R. J., Kaasinen, E., Böhle, A., Palou Redorta, J., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.06.003 · Cited by 1,174
EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
Babjuk, M., Oosterlinck, W., Sylvester, R., Kaasinen, E., Böhle, A., Palou-Redorta, J., & Rouprêt, M. (2011) · European Urology · doi:10.1016/j.eururo.2011.03.017 · Cited by 1,067
Kaufman, D. S., Shipley, W. U., & Feldman, A. S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60491-8 · Cited by 988
Human body fluid proteome analysis
Hu, S., Loo, J. A., & Wong, D. T. (2006) · PROTEOMICS · doi:10.1002/pmic.200600284 · Cited by 533
Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
Davis, R., Jones, J. S., Barocas, D. A., Castle, E. P., Lang, E. K., Leveillee, R. J., Messing, E. M., Miller, S. D., Peterson, A. C., Turk, T. M. T., et al. (2012) · Journal of Urology · doi:10.1016/j.juro.2012.09.078 · Cited by 482
Metadata
- Authors
- Grossman, H. B.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-02-16
- Volume
- 293
- Issue
- 7
- Pages
- 810
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2130116769
- Cited by
- 367
- References
- 15
- FWCI
- 28.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Detection of Bladder Cancer Using a Point-of-Care Proteomic Assay. https://app.cochat.ai/papers/10.1001/jama.293.7.810
- The paper
- Grossman, H. B. (2005). Detection of Bladder Cancer Using a Point-of-Care Proteomic Assay. JAMA. https://doi.org/10.1001/jama.293.7.810
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.